Andreas Rentsch
5Patents
2h-index
15Co-inventors
44Inventor score
Filing activity: Jun 23, 2009 → Sep 1, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11001605B2 | Cyclic dinucleotides containing benzimidazole, method for the production of same, and use of same to activate stimulator of interferon genes (sting)-dependent signaling pathways | Chemistry; Metallurgy | 6 | Active |
| US9458200B2 | Method for producing intermediates for the production of novel macrocycles that are inhibitors of the proteasomic degradation of p27, such as argyrin and derivatives thereof, and uses of said macrocycles | Human Necessities | 2 | Active |
| US10322087B2 | Targeted liposomal delivery of cGMP analogues | Emerging Cross-Sectional Technologies | 1 | Active |
| US11407781B2 | Equatorially modified polymer linked multimers of guanosine-3′, 5′-cyclic monophosphates | Chemistry; Metallurgy | 1 | Active |
| US12384813B2 | Polymer linked multimers of guanosine-3′, 5′-cyclic monophosphates | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.